Article info

Download PDFPDF
Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor α as a new therapeutic option

Authors

  • A K Tausche Section of Internal Medicine, Department of Rheumatology, University Clinic Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, D- 01307 Dresden, Germany PubMed articlesGoogle scholar articles
  • K Richter Section of Internal Medicine, Department of Rheumatology, University Clinic Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, D- 01307 Dresden, Germany PubMed articlesGoogle scholar articles
  • A Grässler Section of Internal Medicine, Department of Rheumatology, University Clinic Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, D- 01307 Dresden, Germany PubMed articlesGoogle scholar articles
  • S Hänsel Section of Internal Medicine, Department of Rheumatology, University Clinic Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, D- 01307 Dresden, Germany PubMed articlesGoogle scholar articles
  • B Roch Section of Internal Medicine, Department of Rheumatology, University Clinic Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, D- 01307 Dresden, Germany PubMed articlesGoogle scholar articles
  • H E Schröder Section of Internal Medicine, Department of Rheumatology, University Clinic Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, D- 01307 Dresden, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to:
    Dr A K Tausche;
    anne-kathrin.tauschemailbox.tu-dresden.de
View Full Text

Citation

Tausche AK, Richter K, Grässler A, et al
Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor α as a new therapeutic option

Publication history

  • Accepted December 1, 2003
  • First published September 10, 2004.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.